The global joint replacement devices market, valued at US$22.50 billion in 2023, is forecasted to grow at a robust CAGR of 4.8%, reaching US$23.42 ...

Q4 2024 Earnings Call Transcript February 6, 2025 Zimmer Biomet Holdings, Inc. beats earnings expectations. Reported EPS is ...

Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, ...

Fourth quarter net sales of $2.023 billion increased 4.3% and 4.9% on a constant currency1 basis Fourth quarter diluted earnings per share were $1.20; adjusted1 ...

During the fourth quarter, Zimmer Biomet received FDA clearance for Persona SoluTion Porous Plasma Spray Femur, a total knee implant ... System for total shoulder replacement is expected to ...

Thus, patients submitted to reoperations, however without the addition or replacement of one or more primary prosthetic ... Implants with two different systems—Legacy Constrained Condylar Knee (Zimmer ...